Acquiring Company
Parse Biosciences
Acquired Company
Biomage
Description
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, has announced its acquisition of data analysis software company Biomage. With this acquisition, customers will have access to a richer suite of single cell data analysis tools through an intuitive interface, empowering researchers with deeper insights and dramatically reduced analysis time.
Quick answer
Parse Biosciences is acquiring Biomage, announced January 16, 2024. Parse Biosciences is based in Seattle, Washington, United States.
- How much did Parse Biosciences pay for Biomage?
- The deal value was not disclosed.
- What does Parse Biosciences do?
- Parse Biosciences is a Seattle-based startup providing researchers access to the most scalable single cell sequencing platform available.
- Where are Parse Biosciences and Biomage based?
- Parse Biosciences is based in Seattle, Washington, United States. Biomage is based in Glasgow, Kentucky, United States.
- Who are the decision-makers at Parse Biosciences?
- Fundz holds 3 contacts at Parse Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Biotechnology Research and Software Development
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Ascent Technologies Acquires Horizon Scanning Solution Provider, Waymark (February 8, 2024)
- Voltron Data Acquires Claypot AI As It Unlocks the Power of the Largest Datasets for AI (January 24, 2024)
- Front Acquires Windsor.io, Accelerating a New Era for AI-powered Customer Service (January 24, 2024)
- Ceridian to Acquire eloomi, a Market-Leading Learning and Development Platform (January 18, 2024)
- Buxton Acquires Elevar to Create Data Powerhouse for Omnichannel Insights and Customer Engagement (January 17, 2024)
- Goodnotes Acquires Korean AI Startup, Dropthebit, to Accelerate Development of AI Features (January 16, 2024)
Who to call at Parse Biosciences, and when
When Parse Biosciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Parse Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Parse Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Parse Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Parse Biosciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Biomage?
Biomage was acquired by Parse Biosciences, based in Seattle. The deal was reported on January 16, 2024. Parse Biosciences is a Seattle-based startup providing researchers access to the most scalable single cell sequencing platform available. Parse Biosciences is privately held and operates in Biotechnology Research.
When did Parse Biosciences acquire Biomage?
Parse Biosciences's acquisition of Biomage was reported on January 16, 2024. Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, has announced its acquisition of data analysis software company Biomage. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Biomage do?
Biomage is a data analysis software company that hosts and supports the largest community instance of Cellenics®, a cloud-based single cell RNA sequencing data analysis platform. It is privately held, operating in Software Development, and is based in Glasgow.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.